• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PERFUSION SYSTEMS CARMEDA AFFINITY PEDIATRIC ARTERIAL BLOOD FILTER; FILTER, BLOOD, CARDIOPULMONARY BYPASS, ARTERIAL LINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PERFUSION SYSTEMS CARMEDA AFFINITY PEDIATRIC ARTERIAL BLOOD FILTER; FILTER, BLOOD, CARDIOPULMONARY BYPASS, ARTERIAL LINE Back to Search Results
Model Number S4014
Device Problem Insufficient Information (3190)
Patient Problems Seizures (2063); Brain Injury (2219); Low Oxygen Saturation (2477)
Event Date 03/20/2018
Event Type  Injury  
Manufacturer Narrative
Event date; month and year valid only.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via a solicitor that a patient is alleged to have suffered oxygen deprivation, seizures, hypoxic ischemic injury and brain damage.A list of devices which included a medtronic arterial filter, blood pump, tubing and cannulae as well as heart lung machine, oxygenator, autotransfusion device and reservoirs from non-medtronic companies.Information was provided that there were flow issues due to clotting and the arterial filter was bypassed.A new circuit was primed and put on standby but was not used.There has not been any communication from the hospital of any malfunction to a medtronic device.
 
Manufacturer Narrative
Investigation conclusion: complaint not confirmed for clotting during use of the pixie arterial filter and observed adverse patient effects.Review of the device history record found no abnormalities or ncmrs initiated during manufacturing that would cause or contribute to the reported event.Clinical review determined that the reported flow and clotting issues were likely related to a patient and/or clinical situation, rather than a malfunction of the medtronic device.Flow issues were noted during bypass initiation, and the arterial filter was bypassed due to clotting.After bypass, clotting was noted throughout the circuit and in the oxygenator.The reported clotting observed on the arterial filter provides evidence that the filter was functioning per the instructions for use (ifu) as the arterial filter is intended to remove particulate and gaseous microemboli from the circuit.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via a lawyer that a patient is alleged to have suffered oxygen deprivation, seizures, hypoxic ischemic injury and brain damage.A list of devices which included a medtronic arterial filter, blood pump, tubing and cannulae as well as heart lung machine, oxygenator, autotransfusion device and reservoirs from non-medtronic companies.Information was provided that there were flow issues due to clotting and the arterial filter was bypassed.A new circuit was primed and put on standby but was not used.There has not been any communication from the hospital of any malfunction to a medtronic device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARMEDA AFFINITY PEDIATRIC ARTERIAL BLOOD FILTER
Type of Device
FILTER, BLOOD, CARDIOPULMONARY BYPASS, ARTERIAL LINE
Manufacturer (Section D)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
MDR Report Key8509373
MDR Text Key141771916
Report Number2184009-2019-00014
Device Sequence Number1
Product Code DTM
Combination Product (y/n)N
PMA/PMN Number
K071253
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 07/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2019
Device Model NumberS4014
Device Catalogue NumberS4014
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/15/2019
Initial Date FDA Received04/12/2019
Supplement Dates Manufacturer Received03/15/2019
Supplement Dates FDA Received07/23/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age4 DA
Patient Weight4
-
-